<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Oct. 7, 2020 (HealthDay News) — Natural fertility is maintained after fertility-sparing surgery (FSS) for women with borderline ovarian tumors (BOTs), with no difference in survival, according to a study published online Sept. 22 in Fertility and Sterility<\/i>.<\/p>\n
Gry Johansen, M.D., from the Karolinska University Hospital in Stockholm, and colleagues assessed the efficacy of FSS on reproductive outcomes (natural conception, use of assisted reproductive technology [ART], live birth, and obstetrical outcomes) among 277 women of reproductive age (18 to 40 years) treated in Sweden for stage I BOTs identified from the Swedish Quality Registry for Gynecologic Cancer (2008 to 2015).<\/p>\n
The researchers found that 77 percent of the women underwent FSS, 86 percent unilateral salpingo-oophorectomy, and 14 percent cystectomy. Fifty women gave birth to 62 healthy children following FSS, with 8 percent of them delivered preterm. Only 20 women (9 percent) underwent ART treatment. Overall survival was similar between women treated with FSS and radical surgery.<\/p>\n
“The ability to become pregnant seems to be preserved with fertility-sparing surgery, a knowledge that is absolutely critical for the advice and treatment given to young women with ovarian borderline tumors,” Johansen said in a statement.<\/p>\n